Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clozapine in the elderly

F R Frankenburg1, D Kalunian

  • 1McLean Hospital, Belmont, MA 02178.

Journal of Geriatric Psychiatry and Neurology
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Clozapine may benefit elderly patients with treatment-resistant psychoses, with six of eight showing improvement. However, two experienced increased confusion, indicating careful monitoring is essential for geriatric psychiatric care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of time-to-attainment of recovery for borderline patients followed prospectively for 16 years.

Acta psychiatrica Scandinavica·2014
Same author

Emotional hypochondriasis, hyperbole, and the borderline patient.

The Journal of psychotherapy practice and research·2012
Same author

Predictors of suicide attempts in patients with borderline personality disorder over 16 years of prospective follow-up.

Psychological medicine·2012
Same author

The 10-year course of PTSD in borderline patients and axis II comparison subjects.

Acta psychiatrica Scandinavica·2011
Same author

The 10-year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects.

Acta psychiatrica Scandinavica·2010
Same author

The course of dissociation for patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study.

Acta psychiatrica Scandinavica·2008
Same journal

Identifying the Barriers and Facilitators to Clinical Implementation of Risk Prediction Tools for Dementia Across UK Primary Care: A Stakeholder Interview Study.

Journal of geriatric psychiatry and neurology·2026
Same journal

Caregiver Reports of Lucid Episodes in Alzheimer's Dementia and Lewy Body Dementias.

Journal of geriatric psychiatry and neurology·2026
Same journal

Neuropsychologists' Engagement With and Cognitive Assessment in Parkinson's Disease: A Mixed Methods Australian Investigation.

Journal of geriatric psychiatry and neurology·2026
Same journal

Attention Networks Connectivity After Cognitive Rehabilitation in Alzheimer's Disease.

Journal of geriatric psychiatry and neurology·2026
Same journal

Associations Between Immigration-Related Factors and Cognition Among Hispanics, the HABS-HD Study.

Journal of geriatric psychiatry and neurology·2026
Same journal

Mild Behavioural Impairment and Everyday Functioning in Cognitively Unimpaired Older Adults: Evidence From the CAN-PROTECT Study.

Journal of geriatric psychiatry and neurology·2026
See all related articles

Area of Science:

  • Geriatric Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Treatment-resistant psychoses present significant challenges in elderly populations.
  • Limited evidence exists on clozapine efficacy and safety in geriatric patients.

Observation:

  • A retrospective review examined clozapine use in eight patients aged 65+ with refractory psychoses.
  • Patient responses to clozapine were systematically documented.

Findings:

  • Six out of eight elderly patients demonstrated clinical improvement with clozapine treatment.
  • Two patients experienced adverse effects, specifically increased confusion, necessitating close observation.

Implications:

  • Clozapine is a potential therapeutic option for elderly individuals with treatment-resistant psychoses.

Related Experiment Videos

  • The use of clozapine in geriatric psychiatry may extend beyond schizophrenia.
  • Further research is warranted to optimize clozapine dosing and monitoring in the elderly.